The CSCB is generating and characterising new embryonic stem cell lines for clinical applications. This involves the production of clinical grade cell lines and master cell banks that can meet the stringent requirements of healthcare regulators. New technologies to increase efficiency are tested and the pluripotent capacity of different cell lines evaluated. We are also investigating gamete (sperm and egg) and trophoblast (placental) stem cells.
Developing new cryopreservation techniques for stem cells. Ensures that cell lines are of the correct quality and free of any contaminants. Trains new staff and visitors in the culture of embryonic stem cells.
Email: K.Amps@sheffield.ac.uk
Manages the production of clinical grade cell lines in our Stem Cell Derivation Facility. This involves the creation of master stem cell banks which will be used for cell therapies for many years to come.
Email: G.Bray@sheffield.ac.uk
Producing clinical grade stem cell lines and developing new technologies to increase efficiency.
Email: g.cleaver@sheffield.ac.uk
Implements and manages all the processes and procedures required to produce our embryonic stem cell lines to a clinical standard. As a Designated Individual Zoe is responsible for ensuring the cells meet the stringent criteria of the Human Tissue Authority.
Email: Z.Hewitt@sheffield.ac.uk
Investigating the development of retinal cells from pluripotent stem cells for the treatment of blindness. (supported by the BBSRC)
Email: c.owen@sheffield.ac.uk
Ensures that clinical grade cell lines are produced to high quality and free of any contaminants.
Email: H.Spink@sheffield.ac.uk
Producing clinical grade stem cell lines and developing new technologies to increase efficiency.
Email: r.weightman@sheffield.ac.uk
Assists in ensuring clinical grade cell lines are produced to high quality and free of any contaminants.
Email: Andy.Wood@sheffield.ac.uk